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A 69-year-old female diagnosed with MS 27 year ago.  Symptoms began as 
weakness in the left leg that would come and go.  The weakness slowly spread to 
the right side of the body.  The patient went to the doctor when the right side 
went completely weak.  At the beginning of the disease process the patient was 
not on any medications.  When there was an exacerbation, the patient would be 
off work for two or three weeks.  Resting aided in recovery.  No medications 
were taken at this time.  
The first MS drug tried was Betaseron, for approximately 10 years.  During 
this time there would be exacerbations approximately every two years.  Rest and 
IV steroids would aid in recovery.  
The patient was taken off of Betaseron with a new neurologist due to the side 
effect of depression, which the patient was experiencing.  The medication 
Copaxone was taken, but the results were not desired, so it was discontinued.  
For several years the patient was not on any medication for MS.  Two years ago, 
Ocrevus was started.  The patient is very pleased with the results.  There are no 
new lesions on the current MRI.   
The main symptom the patient has is weakness in legs which has caused 
progressive loss of function leading to using a progression from a cane, to a 
walker, then to a wheelchair for mobility.  Fatigue, incontinence, depression, and 
feeling useless are other symptoms the patient reports. 
Aggravating factors are heat, humidity, stress, and negative people.  Relieving 
factors are working on crafts, being outside when able, bible study, reading, and 
watching tv.  There is no family history of MS.  
Multiple sclerosis (MS) is an 
advanced pathophysiological 
disease that is relevant to 
advanced practice nursing. It is the 
“most common immune-mediated 
inflammatory demyelinating 
disease of the central nervous 
system” (Olek & Howard, 2019).  
The exact cause of MS is still 
unknown; however, it is 
characterized by exacerbations of 
neurological dysfunction due to 
inflammatory demyelination 
(Huang, Chen, & Zhang, 2017).  
Consequently, the treatment of 
MS requires a multi-disciplinary 
approach, with nurses at the heart 
of the team. Hence, an advanced 
practice nurse will need to be able 
to recognize the signs and 
symptoms of MS for a proper 
diagnosis and must be familiar 
with the current trends in patient 
management and treatments of 
the disease.  This help to support 
and advocate for best available 
intervention strategies acceptable 
to the patient and relevant to 





































The	unknown	exact	cause	of	MS,	the	wide	variety	in	symptoms,	and	the	unpredictability	of	the	disease	course	has	significant	implications	for	the	patient	and	the	nurse.		Feys et	al.	(2016)	suggests	a	multi-disciplinary	approach	to	adequately	meet	all	of	the	patients	complex	and	often	changing	needs.		This	team	can	include	a	neurologist,	nurse,	primary	care	provider,	other	specialists,	and	professionals	outside	of	the	health	care	sector	(Feys et	al.,	2016).		Many	new	management	options	have	been	found	in	the	past	20	years	(D’haeseleer,	2015).		Nurses	need	to	keep	up	with	changes	in	treatments	to	help	educate	patients	not	only	about	current	options,	but	side	effects	as	well.		The	focus	of	the	care	needs	to	be	the	improvement	of	quality	of	life	and	the	patient’s	ability	to	work	(Kamm	et	al.,	2014).		Suggestions	for	nurses	can	include	linking	the	patient	with	accessibility	resources	or	occupational	therapy.			People	who	have	MS	noted	the	feeling	of	invisibility	(Žiaková,	Čáp,	Miertová,	&	Gurková,	2019).	The	nurse	needs	to	keep	this	in	mind	and	address	questions	to	the	patient,	not	a	care	giver.		The	patient	also	might	have	cognitive	or	speech	delays	and	would	need	more	time	to	answer	questions.		The	patients	care	giver	is	also	affected,	indirectly	and	must	be	considered	by	the	nurse	as	well	(Feys et	al.,	2016).
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